How to Compete With Hims, Ro, and the Big Telehealth Brands

Every telehealth founder thinks about this question. They see Hims and Ro spending hundreds of millions of dollars a year on advertising, dominating share of voice, and treating every emerging category as a feature on their platform. The honest answer is that you cannot outspend them. You also do not have to. The biggest telehealth brands have specific structural weaknesses that smaller, more focused brands can exploit.

Here is how challenger telehealth brands actually win in 2026: where the giants are weak, what positioning works, and the moves that compound when you cannot match their budget.

Where the Big Brands Are Strong

Brand awareness. The big telehealth brands have spent years on prime-time TV, podcast ads, and out-of-home. Most US adults can name Hims or Ro. Trying to match them on awareness is a losing game.

Multi-category breadth. The giants offer six to ten categories under one roof. A patient on weight loss can also get hair loss, ED, anxiety, and skincare without switching providers.

Operating leverage. They have infrastructure, pharmacy partnerships, and prescriber networks that took years to build. Trying to replicate this at smaller scale rarely makes sense.

Where the Big Brands Are Weak

Category depth. A platform serving ten categories cannot go deeper than two paragraphs on any one. A focused brand can publish 50 articles, three video series, and a referral pipeline specifically about its single category.

Provider intimacy. Big platforms have to standardize the provider experience. A focused brand can build genuine clinical relationships, named providers, and the kind of trust signals patients cannot get from a multi-category platform.

Niche audiences. Hair loss for Black men. Weight loss for women over 50. TRT for endurance athletes. Peptide therapy for biohackers. The giants serve generic audiences. The challengers who own a niche win the niche.

Pricing innovation. The big brands have locked in pricing structures that are hard to change. Challengers can introduce new pricing models (cash-pay compounded, annual prepay, bundled packages) without internal politics.

The Positioning That Actually Beats Them

Specialist authority. Be the brand for one category, not the brand for everything. A "weight loss telehealth" positioning beats a "men's health" positioning when you are competing in weight loss. Specialization signals depth.

Patient profile specificity. The big brands market to broad demographics. Challengers market to specific people: women over 40 dealing with menopause-related weight gain, men in their 30s with low energy who do not want a clinic, recovering athletes who need supervised hormone optimization.

Trust through transparency. Real providers with real names, real pharmacies with real licenses, real pricing with no surprise renewals. Big brands obscure these details for operational reasons. Challengers can lead with them.

Marketing Moves That Beat Spend

Content depth in one category. While the giants publish thin content across ten verticals, a focused brand can build a pillar-and-cluster content engine that ranks for every long-tail commercial intent query in its niche.

Provider-led creative. Big brands lean on UGC creators and stock-style videos. Challengers can put real, named providers on camera, which lifts trust and conversion dramatically in trust-sensitive categories.

Community building. Owning a private community for your category (Facebook group, Discord, Reddit-style forum) compounds awareness and acquisition in ways paid spend never will.

Referral economics. Focused brands have more loyal patients, which makes referral programs more powerful. A 10% referral rate on a sticky cohort beats a 2% referral rate on a transactional one.

Channels Where Challengers Win

Long-tail SEO. Hims and Ro do not rank for "TRT telehealth for endurance athletes" or "GLP-1 for women over 50 with PCOS." Niche-specific long-tail content is the highest-leverage organic channel for telehealth challengers in 2026.

Niche-specific paid social audiences. Meta will let you target very specific audience profiles. The giants run broad campaigns; challengers can run highly tuned campaigns to specific personas where their offer is sharper than the generalist option.

Podcast advertising in vertical-specific shows. The big brands buy general-audience podcasts. Challengers can sponsor smaller, niche-specific podcasts where the audience overlap is 80-90% with their target patient.

Reddit and niche community channels. Most big brands cannot or will not engage authentically in subreddit communities. Challengers who do well here build trust no ad budget can buy.

What Not to Do

Do not try to launch in five categories on day one because the giants do. The reason they can do it is operational maturity you do not have yet. Pick one category, own it, expand later.

Do not try to compete on price alone. Cheap positioning is a race to the bottom and signals lower quality to most telehealth patients. Compete on depth, trust, and clinical experience.

Do not run generic creative because that is what the giants run. Specific creative outperforms generic creative when you do not have brand recognition to coast on.

Do not delay building owned audiences. Email lists, SMS subscribers, and community memberships are the durable assets that compound while paid CAC drifts up.

The Short Version

You cannot outspend Hims, Ro, or the other giants in telehealth in 2026. You can out-position them, out-specialize them, and out-trust them in a niche. The challengers who win pick one category, build real depth, lead with credentialed providers, invest in compounding owned channels, and treat paid social as a steady engine rather than a magic growth lever. Focus beats budget when the budget gap is large.